DNTH logo

Dianthus Therapeutics, Inc. (DNTH) Cash From Investing

Annual CFI:

-$286.81M-$307.06M(-1516.15%)
December 31, 2024

Summary

  • As of today (October 5, 2025), DNTH annual cash from investing is -$286.81 million, with the most recent change of -$307.06 million (-1516.15%) on December 31, 2024.
  • During the last 3 years, DNTH annual cash from investing has fallen by -$330.24 million (-760.43%).
  • DNTH annual cash from investing is now -760.43% below its all-time high of $43.43 million, reached on December 31, 2021.

Performance

DNTH Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHcash flow metrics

Quarterly CFI:

$26.45M+$11.65M(+78.75%)
June 30, 2025

Summary

  • As of today (October 5, 2025), DNTH quarterly cash from investing is $26.45 million, with the most recent change of +$11.65 million (+78.75%) on June 30, 2025.
  • Over the past year, DNTH quarterly cash from investing has increased by +$25.28 million (+2162.19%).
  • DNTH quarterly cash from investing is now -58.56% below its all-time high of $63.81 million, reached on September 1, 2019.

Performance

DNTH Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHcash flow metrics

TTM CFI:

-$241.24M+$25.28M(+9.48%)
June 30, 2025

Summary

  • As of today (October 5, 2025), DNTH TTM cash from investing is -$241.24 million, with the most recent change of +$25.28 million (+9.48%) on June 30, 2025.
  • Over the past year, DNTH TTM cash from investing has dropped by -$217.16 million (-901.81%).
  • DNTH TTM cash from investing is now -345.05% below its all-time high of $98.44 million, reached on June 1, 2020.

Performance

DNTH TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

DNTH Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-1516.2%+2162.2%-901.8%
3Y3 Years-760.4%+10000.0%-604.8%
5Y5 Years-10000.0%+76.7%-541.7%

DNTH Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-760.4%at lowat high+110.2%-1279.7%+15.9%
5Y5-Year-760.4%at low-11.5%+110.2%-541.7%+15.9%
All-TimeAll-Time-760.4%at low-58.6%+110.2%-345.1%+15.9%

DNTH Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$26.45M(+78.8%)
-$241.24M(-9.5%)
Mar 2025
-
$14.79M(-164.0%)
-$266.51M(-7.1%)
Dec 2024
-$286.81M(-1516.1%)
-$23.11M(-91.1%)
-$286.81M(+5.5%)
Sep 2024
-
-$259.36M(<-9900.0%)
-$271.94M(+1029.3%)
Jun 2024
-
$1.17M(-121.2%)
-$24.08M(+611.4%)
Mar 2024
-
-$5.51M(-33.1%)
-$3.38M(-116.7%)
Dec 2023
$20.25M(-133.9%)
-$8.24M(-28.4%)
$20.25M(+28.0%)
Sep 2023
-
-$11.51M(-152.6%)
$15.82M(-22.6%)
Jun 2023
-
$21.86M(+20.6%)
$20.45M(-1424.4%)
Mar 2023
-
$18.13M(-243.2%)
-$1.54M(-97.4%)
Dec 2022
-$59.82M(-237.7%)
-$12.66M(+84.1%)
-$59.82M(+4.1%)
Sep 2022
-
-$6.88M(+5234.1%)
-$57.48M(+67.9%)
Jun 2022
-
-$129.00K(-99.7%)
-$34.23M(+713.2%)
Mar 2022
-
-$40.14M(+288.9%)
-$4.21M(-109.7%)
Dec 2021
$43.43M
-
-
Dec 2021
-
-$10.32M(-163.1%)
$43.43M(-352.2%)
Sep 2021
-
$16.37M(-45.2%)
-$17.22M(+26.5%)
Jun 2021
-
$29.89M(+298.9%)
-$13.61M(-52.3%)
DateAnnualQuarterlyTTM
Mar 2021
-
$7.49M(-110.6%)
-$28.54M(+168.3%)
Dec 2020
-$10.63M(-794.2%)
-$70.97M(-455.2%)
-$10.63M(-119.5%)
Sep 2020
-
$19.98M(+33.5%)
$54.62M(-44.5%)
Jun 2020
-
$14.96M(-41.1%)
$98.44M(+148.2%)
Mar 2020
-
$25.39M(-543.7%)
$39.66M(+2488.6%)
Dec 2019
$1.53M(-101.7%)
-$5.72M(-109.0%)
$1.53M(-101.9%)
Sep 2019
-
$63.81M(-245.6%)
-$79.36M(-45.5%)
Jun 2019
-
-$43.82M(+244.2%)
-$145.64M(+39.7%)
Mar 2019
-
-$12.73M(-85.3%)
-$104.27M(+13.7%)
Dec 2018
-$91.70M(+4070.2%)
-$86.61M(+3399.6%)
-$91.70M(+1702.0%)
Sep 2018
-
-$2.48M(+0.9%)
-$5.09M(+69.7%)
Jun 2018
-
-$2.45M(+1423.6%)
-$3.00M(+86.0%)
Mar 2018
-
-$161.00K(-58.2%)
-$1.61M(-20.1%)
Dec 2017
-$2.20M(+1482.0%)
-
-
Sep 2017
-
-$385.00K(-63.9%)
-$2.02M(+23.6%)
Jun 2017
-
-$1.07M(+88.3%)
-$1.63M(+188.3%)
Mar 2017
-
-$566.00K
-$566.00K
Dec 2016
-$139.00K
-
-

FAQ

  • What is Dianthus Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Dianthus Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Dianthus Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Dianthus Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of DNTH is -$286.81M

What is the all-time high annual cash from investing for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high annual cash from investing is $43.43M

What is Dianthus Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, DNTH annual cash from investing has changed by -$307.06M (-1516.15%)

What is Dianthus Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of DNTH is $26.45M

What is the all-time high quarterly cash from investing for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high quarterly cash from investing is $63.81M

What is Dianthus Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, DNTH quarterly cash from investing has changed by +$25.28M (+2162.19%)

What is Dianthus Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of DNTH is -$241.24M

What is the all-time high TTM cash from investing for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high TTM cash from investing is $98.44M

What is Dianthus Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, DNTH TTM cash from investing has changed by -$217.16M (-901.81%)
On this page